Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cbd Life Sciences Inc (OP: CBDL )

0.0005 +0.0001 (+25.00%)
Streaming Delayed Price Updated: 3:52 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,436,137
Open 0.0005
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0004
Today's Range 0.0004 - 0.0005
52wk Range 0.0001 - 0.0224
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CBD Life Sciences Inc. (CBDL) in Final Stages to Sell CBD Products on DoorDash Platform
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth
Via ACCESSWIRE

Performance

YTD
N/A
N/A
1 Month
+25.00%
+25.00%
3 Month
-16.67%
-16.67%
6 Month
-44.44%
-44.44%
1 Year
+400.00%
+400.00%

More News

Read More
CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
Via ACCESSWIRE
CBDNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CBD Life Sciences Inc. (CBDL) Targets Amazon Marketplace for Strategic Business Enhancements
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace
Via ACCESSWIRE
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Unveils Mellow Mornings: A Revolutionary Nano CBD Coffee Creamer Set to Boost Revenue Amid Growing National Demand
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces MOU With New York Dispensary, Poised for Significant Revenue Growth and Shareholder Value
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.